05.20.25 -- A Checklist For Mechanism-Based Potency Testing In Cell Therapy

Set your new drug development program up for success by knowing which obstacles to avoid when outsourcing nonclinical research. Watch this informative video today!

Learn more about this cost-effective, efficient alternative to traditional Protein A resin chromatography for mAb production, enhancing productivity and reducing costs.

What if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines and manufacturing considerations for dry powder inhaled vaccines.

The prevalence of active compounds with low aqueous solubility exceeds 70% in drug pipelines, preventing the development of many compounds as effective medicines. 

Overcoming the limitations of current proximity inducers requires optimizing cooperativity. Learn how enhancing target affinity can lead to smaller, more effective therapeutics with better safety profiles.

A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.